Scientists have discovered a surprising link between leukemia and autoimmune diseases. A new study shows that certain genetic changes connected to leukemia can also create abnormal immune cells that mistakenly attack the body.
This discovery helps explain why some people with leukemia also develop autoimmune conditions such as rheumatoid arthritis or aplastic anemia.
The research was carried out by scientists at the Garvan Institute of Medical Research in Australia. Their findings provide new insight into how the immune system can go wrong and lead to both cancer and autoimmune disease. The study was led by Dr. Etienne Masle‑Farquhar and the results were published in the scientific journal Immunity.
To understand this discovery, it helps to know how the immune system normally works. The immune system is the body’s natural defense system.
Its job is to protect us from harmful threats such as viruses, bacteria, and abnormal cells. One important group of immune cells is known as T cells. These cells act like soldiers that patrol the body looking for danger.
Among these T cells are special defenders called “killer T cells.” Their job is to destroy infected or damaged cells before they cause harm. When the immune system works properly, killer T cells carefully target dangerous cells and leave healthy cells alone.
However, the new study shows that this system can sometimes break down. When certain genes change, killer T cells may begin to behave abnormally. Instead of protecting the body, these cells multiply too quickly and begin attacking healthy tissue. When the immune system attacks the body in this way, it leads to autoimmune disease.
Doctors have long noticed that some patients with leukemia also develop autoimmune disorders. Leukemia is a type of cancer that affects blood cells and the bone marrow. It happens when abnormal blood cells grow out of control. Until recently, scientists did not fully understand why leukemia and autoimmune disease sometimes appear together.
To investigate this question, the research team studied blood samples from children who had rare inherited autoimmune diseases. These conditions are caused by genetic changes that affect the immune system. By studying these patients, the scientists hoped to learn how immune cells become harmful.
The researchers also used a powerful gene‑editing technology called CRISPR/Cas9 to study the problem in mice. This tool allows scientists to precisely change genes and observe how those changes affect cells. By using this method, the team could examine what happens when specific genes linked to leukemia are altered.
The scientists focused on a protein called STAT3. This protein plays an important role in controlling how immune cells grow and respond to signals in the body. Under normal conditions, STAT3 helps keep the immune system balanced and prevents immune cells from becoming too aggressive.
The study showed that when the STAT3 gene is changed, killer T cells begin to behave very differently. The cells grow larger than normal and stop responding to the signals that usually control their activity. Because of this, they continue multiplying and attacking healthy tissue.
One of the most surprising findings was how few rogue cells are needed to cause serious disease. The researchers found that even if only 1 to 2 percent of the immune cells become abnormal, they can still trigger severe autoimmune conditions. This means a very small number of malfunctioning cells can have a powerful impact on the whole immune system.
The discovery is important because it may lead to better treatments in the future. By understanding exactly how these rogue immune cells develop, doctors may be able to design therapies that target them more precisely. Some existing medications may already help.
For example, drugs known as JAK inhibitors are currently approved in Australia by the Therapeutic Goods Administration. These medicines affect pathways related to STAT3 and could potentially be used more effectively when doctors understand a patient’s specific genetic changes.
The researchers also discovered new information about two groups of receptors that immune cells use to communicate when the body is under stress. These receptors help immune cells sense danger and respond appropriately.
Learning more about how these communication systems work may allow scientists to stop harmful immune cells before they begin attacking the body.
In the future, doctors may also be able to detect these problems earlier. Advanced blood tests could analyze the immune system at the genetic level. This type of testing could reveal small changes in immune cells long before symptoms appear. If doctors can identify these warning signs early, they may be able to prevent autoimmune diseases from developing.
Overall, this research represents an important step forward in understanding how the immune system can become unbalanced. By showing how small genetic changes can create rogue immune cells, scientists have uncovered a key link between leukemia and autoimmune disease.
The discovery gives researchers new clues about how these serious illnesses begin and how they might be treated more effectively in the future. With further study, this knowledge may help doctors develop better ways to prevent, manage, and treat both leukemia and autoimmune conditions.
If you care about cancer, please read studies about Researchers find a new cause of cancer and findings of Scientists make a big breakthrough in prostate cancer treatment.
If you care about cancer, please read studies about Research finds a new cause of cancer growth and findings of Scientists find the missing link between autoimmune diseases and blood cancer.
Copyright © 2026 Knowridge Science Report. All rights reserved.
